NO2662073T3 - - Google Patents

Info

Publication number
NO2662073T3
NO2662073T3 NO13167187A NO13167187A NO2662073T3 NO 2662073 T3 NO2662073 T3 NO 2662073T3 NO 13167187 A NO13167187 A NO 13167187A NO 13167187 A NO13167187 A NO 13167187A NO 2662073 T3 NO2662073 T3 NO 2662073T3
Authority
NO
Norway
Application number
NO13167187A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2662073T3 publication Critical patent/NO2662073T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NO13167187A 2012-05-09 2013-05-09 NO2662073T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1422MU2012 2012-05-09

Publications (1)

Publication Number Publication Date
NO2662073T3 true NO2662073T3 (pl) 2018-04-07

Family

ID=48288939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13167187A NO2662073T3 (pl) 2012-05-09 2013-05-09

Country Status (7)

Country Link
US (2) US20130303453A1 (pl)
EP (1) EP2662073B1 (pl)
JP (1) JP2013234184A (pl)
DK (1) DK2662073T3 (pl)
ES (1) ES2659166T3 (pl)
NO (1) NO2662073T3 (pl)
PL (1) PL2662073T3 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110678194B (zh) * 2017-05-15 2024-08-06 太阳制药有限公司 奥曲肽注射液
JP1631155S (pl) 2017-11-06 2019-05-13
USD863549S1 (en) * 2018-07-03 2019-10-15 Haselmeier Ag Medical injector
USD878566S1 (en) * 2018-07-03 2020-03-17 Haselmeier Ag Medical injector
USD878567S1 (en) * 2018-07-03 2020-03-17 Haselmeier Ag Medical injector
ES2902784T3 (es) 2019-10-24 2022-03-29 Sun Pharmaceutical Ind Ltd Una forma de dosificación parenteral estable de acetato de Cetrorelix
US11052196B1 (en) 2020-11-03 2021-07-06 Sun Pharmaceutical Industries Limited Method of injecting octreotide acetate into the body

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641206B2 (en) * 1991-01-22 1993-09-16 Eli Lilly And Company Multiple dose injection pen
EP1589901A4 (en) * 2002-12-20 2006-08-09 Generipharm Inc INTRAKUTANE INJECTION
DK1742616T3 (en) * 2004-04-30 2015-01-12 Abraxis Bioscience Llc The microsphere-discharge-system for the prolonged delivery and methods of making and using the same
JP2007204391A (ja) * 2006-01-31 2007-08-16 Osaka Medical College モノクロロ酢酸曝露用初期救急処置セット
WO2010115762A1 (en) * 2009-04-01 2010-10-14 Sanofi-Aventis Deutschland Gmbh Pen-type drug delivery device with luminous markers
JP5859987B2 (ja) * 2010-02-24 2016-02-16 アレコー リミテッド タンパク質製剤

Also Published As

Publication number Publication date
EP2662073B1 (en) 2017-11-08
EP2662073A1 (en) 2013-11-13
PL2662073T3 (pl) 2018-04-30
ES2659166T3 (es) 2018-03-14
DK2662073T3 (en) 2018-02-12
US20140213984A1 (en) 2014-07-31
US20130303453A1 (en) 2013-11-14
JP2013234184A (ja) 2013-11-21

Similar Documents

Publication Publication Date Title
BR112014019882A2 (pl)
BR112014017614A2 (pl)
BR112014018117A2 (pl)
BR112014017625A2 (pl)
BR112014017659A2 (pl)
BR112014017607A2 (pl)
BR112014017646A2 (pl)
AR092201A1 (pl)
BR112013027865A2 (pl)
BR112014017644A2 (pl)
BR112014017634A2 (pl)
BR112014018021A2 (pl)
BR112014017647A2 (pl)
BR112014017618A2 (pl)
BR112014019767A2 (pl)
BR112014019360A2 (pl)
BR112014017627A2 (pl)
BR112014017623A2 (pl)
BR112014017652A2 (pl)
BR112014017630A2 (pl)
BR112014017641A2 (pl)
BR112014017621A2 (pl)
BR112014017631A2 (pl)
BR112014019212A2 (pl)
BR112014017671A2 (pl)